Literature DB >> 3142719

Effect of albumin supplementation during parenteral nutrition on hospital morbidity.

R O Brown1, J E Bradley, W B Bekemeyer, R W Luther.   

Abstract

Because several studies have shown a significant inverse correlation between depressed serum concentrations of albumin and hospital morbidity, a study with central total parenteral nutrition (TPN) with normal serum albumin (NSA) in hypoalbuminemic patients was conducted. Sixty-one patients who required central TPN were randomized into one of two groups: group 1 (n = 31) received TPN plus NSA (25 to 37.5 g/day) until their measured serum albumin was greater than 3 g/dl, and group 2 (n = 30), who received TPN alone. All patients were followed for hospital complications until discharge or death. The groups were well matched for age, sex, major diagnoses, initial serum albumin concentrations, hospital complications before TPN, and number of operative procedures. Both groups received comparable doses of energy (37.2 +/- 89 vs. 3.30 +/- 6.2 kcal/kg.day) and protein (1.6 +/- 0.4 vs. 1.6 +/- 0.3 g/kg.day). After initiation of TPN, there were significantly more hospital complications in group 2 (1 = 1.1 +/- 1.4, n = 33; 2 = 2.6 +/- 3.0, n = 80, p less than .01). When complications in the patient groups were stratified, significantly more patients in group 2 developed pneumonia (18 vs. 9, p less than .05) and septicemia (11 vs. 2, p less than .05). Increasing serum albumin concentrations with NSA in hypoalbuminemic patients receiving central TPN appears to be associated with a reduction in hospital morbidity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3142719     DOI: 10.1097/00003246-198812000-00002

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  18 in total

Review 1.  Human albumin solution for resuscitation and volume expansion in critically ill patients.

Authors:  Ian Roberts; Karen Blackhall; Phil Alderson; Frances Bunn; Gillian Schierhout
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

Review 2.  [Intensive insulin therapy in sepsis. Improvement of survival chances?].

Authors:  M G Jeschke
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

3.  Burns and ulcerative colitis.

Authors:  O Castana; M Makrodimou; G Mantzaris; Z Tsandoulas; S Prigouris; D Alexakis
Journal:  Ann Burns Fire Disasters       Date:  2006-09-30

4.  Concerning Chapter 5 - Human Albumin; in Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives, 4th ed. Transfus Med Hemother 2009;36(6):399-407.

Authors:  Albert Farrugia
Journal:  Transfus Med Hemother       Date:  2010-03-15       Impact factor: 3.747

5.  Wonderful albumin?

Authors:  N Soni
Journal:  BMJ       Date:  1995-04-08

6.  'What's the serum albumin?'.

Authors:  N Williams; A D Scott
Journal:  Ann R Coll Surg Engl       Date:  1998-03       Impact factor: 1.891

Review 7.  In my opinion: serum albumin should be maintained during neurocritical care.

Authors:  David J Powner
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

Review 8.  Exploding the albumin myth.

Authors:  M M Tjoeng; A K Bartelink; L G Thijs
Journal:  Pharm World Sci       Date:  1999-02

9.  Insulin-like growth factor I in combination with insulin-like growth factor binding protein 3 affects the hepatic acute phase response and hepatic morphology in thermally injured rats.

Authors:  M G Jeschke; D N Herndon; R E Barrow
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

10.  Factors of importance for the long term prognosis after hospital treated pneumonia.

Authors:  J U Hedlund; A B Ortqvist; M E Kalin; F Granath
Journal:  Thorax       Date:  1993-08       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.